Apella Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.27M Buy
43,902
+6,239
+17% +$862K 0.08% 165
2026
Q2
$4.85M Buy
37,663
+526
+1% +$61.6K 0.07% 167
2026
Q1
$4.42M Buy
37,137
+22,436
+153% +$2.59M 0.07% 174
2025
Q4
$1.55M Buy
14,701
+775
+6% +$72.8K 0.03% 233
2025
Q3
$1.17M Buy
13,926
+2,579
+23% +$212K 0.03% 234
2025
Q2
$918K Buy
11,347
+492
+5% +$39.1K 0.02% 229
2025
Q1
$889K Buy
10,855
+1,385
+15% +$129K 0.03% 196
2024
Q4
$942K Buy
9,470
+423
+5% +$43.6K 0.04% 168
2024
Q3
$1.01M Buy
9,047
+1,044
+13% +$124K 0.04% 148
2024
Q2
$1.01M Buy
8,003
+1,846
+30% +$238K 0.05% 147
2024
Q1
$780K Buy
6,157
+359
+6% +$44.2K 0.04% 157
2023
Q4
$678K Sell
5,798
-133
-2% -$13.8K 0.04% 165
2023
Q3
$611K Buy
5,931
+256
+5% +$27.6K 0.04% 153
2023
Q2
$655K Buy
+5,675
New +$644K 0.05% 151
2022
Q4
$707K Buy
6,374
+1,705
+37% +$174K 0.06% 131
2022
Q3
$402K Buy
4,669
+247
+6% +$22K 0.05% 150
2022
Q2
$403K Buy
4,422
+91
+2% +$8.07K 0.05% 159
2022
Q1
$355K Buy
4,331
+84
+2% +$6.62K 0.05% 151
2021
Q4
$325K Sell
4,247
-700
-14% -$55.8K 0.04% 159
2021
Q3
$372K Sell
4,947
-1,211
-20% -$92.1K 0.05% 149
2021
Q2
$479K Sell
6,158
-1,103
-15% -$82K 0.08% 139
2021
Q1
$534K Sell
7,261
-1,253
-15% -$92.4K 0.17% 81
2020
Q4
$665K Sell
8,514
-347
-4% -$26.5K 0.23% 72
2020
Q3
$701K Buy
8,861
+446
+5% +$34.9K 0.28% 68
2020
Q2
$621K Hold
8,415
– – 0.29% 71
2020
Q1
$618K Buy
+8,415
New +$661K 0.36% 62

Other funds holding MRK

Apella Capital's MRK Position: Q3 2026 in Review

Apella Capital increased its Merck (MRK) stake by 17% in Q3 2026, buying an estimated $862K and bringing the position to 43,902 shares worth $6.27M. The position accounts for 0.08% of the portfolio, ranked #165.

Apella Capital first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Apella Capital held 43,902 shares of Merck worth $6.27M as of Q3 2026.
  • Apella Capital bought 6,239 Merck shares in Q3 2026, an estimated $862K.
  • Merck made up 0.08% of Apella Capital's portfolio in Q3 2026, its #165 holding.
  • Apella Capital first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.